台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.30
  • 漲跌
    ▼0.40
  • 漲幅
    -0.94%
  • 成交量
    132
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生華科 (6492)籌碼相關-群益金鼎-彰化 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-彰化 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1000.00043.8043.350387-0.01%
2025/01/0900.000.143.5443.95-0.1386-0.03%
2025/01/0800.001.143.2142.70-1.1384-0.27%
2025/01/07142.5500.0042.8013890.26%
2025/01/0600.00143.8043.40-1395-0.25%
2025/01/03042.75043.8542.3004020.00%
2024/12/301.243.45044.0543.001.24180.28%
2024/12/2700.00345.3744.25-3421-0.72%
2024/12/18142.2100.0042.3015150.20%
2024/12/12043.2000.0042.9505910.01%
2024/12/04145.2500.0045.3516200.16%
2024/11/22245.9300.0045.3526690.30%
2024/11/2100.00245.2845.65-2671-0.30%
2024/11/2000.00145.5045.10-1682-0.15%
2024/11/1800.001345.1044.10-13699-1.86%
2024/11/14146.7000.0046.4517050.14%
2024/11/11148.8000.0048.3517310.14%
2024/10/29452.48152.6052.1037720.39%
2024/10/281055.68256.6052.6087561.06%
2024/10/25451.45254.4054.4026450.31%
2024/10/23250.0000.0050.0026280.32%
2024/10/2200.00349.6049.60-3646-0.46%
2024/09/30755.50754.7054.4001,0460.00%
2024/09/27153.80154.1054.7001,0350.00%
2024/09/1900.00655.6353.20-6995-0.60%
2024/09/13448.5900.0047.8049670.41%
2024/09/05248.1000.0047.4021,0180.20%
2024/08/2200.00150.9049.80-1962-0.10%
2024/08/21350.5000.0050.6039480.32%
2024/08/1500.00248.5549.60-2917-0.22%
2024/08/14147.4000.0047.0519010.11%
2024/08/12148.65248.8548.15-1885-0.11%
2024/08/0900.00248.6548.15-2879-0.23%
2024/08/08150.20449.5549.75-3865-0.35%
2024/08/0600.00150.0049.00-1841-0.12%
2024/08/05147.7000.0047.7018180.12%
2024/08/02154.5000.0053.0018090.12%
2024/07/3100.00255.8056.50-2799-0.25%
2024/07/26153.7000.0054.5017760.13%
2024/07/22157.001057.2056.20-9752-1.20%
2024/07/19260.25360.4058.10-1735-0.14%
2024/07/182161.081261.2462.2096581.36%
2024/07/17956.37658.4058.9035430.55%
2024/07/16356.5000.0057.2034270.70%
2024/07/1500.00152.0052.00-1337-0.30%
2024/07/1200.0011.147.3047.30-11.1328-3.37%
2024/07/10243.2800.0043.3523190.64%
2024/07/09243.4000.0043.4023190.63%
2024/07/042.244.6800.0044.852.23100.71%
2024/07/033.445.2000.0045.003.43081.10%
2024/07/022.545.9500.0045.502.53070.81%
2024/06/2700.00048.0747.100296-0.01%
2024/06/2600.00246.3048.75-2288-0.70%
2024/06/25245.0000.0045.2022640.76%
2024/06/2400.00146.1645.50-1262-0.39%
2024/06/211.145.48247.5545.20-0.9258-0.36%
2024/06/20449.100.148.9047.603.92501.55%
2024/06/1900.00445.3847.95-4224-1.79%
2024/06/18444.8100.0044.0042131.87%
2024/06/1700.00345.1245.35-3187-1.62%
2024/06/13241.5800.0041.4521531.30%
2024/06/06142.45042.9542.3511510.66%
2024/05/2800.00142.0042.30-1164-0.61%
2024/05/27141.5000.0041.3511640.61%
2024/05/2200.00243.0543.25-2174-1.14%
2024/05/20242.2800.0041.9521741.15%
2024/05/170.141.8500.0042.450.11770.05%
2024/05/160.141.85342.2041.70-2.9177-1.62%
2024/05/15141.6500.0041.7011780.56%
2024/05/09241.6500.0041.3521801.11%
2024/05/0600.00241.9341.75-2181-1.10%
2024/03/2100.00042.6042.7002000.00%
2024/03/01244.9000.0044.2523440.58%
2024/02/16046.9500.0046.7504260.00%
2024/02/1500.00246.2046.00-2436-0.46%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音